USFDA inspects Cadila Healthcare’s formulations manufacturing facility at Baddi

09 Mar 2020 Evaluate

The US Food and Drug Administration (USFDA) has inspected Cadila Healthcare’s formulations manufacturing facility located at Baddi from March 2-9, 2020. This was a cGMP and Post Approval Inspection. At the end of the inspection, no observation (483) is issued.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

885.00 0.15 (0.02%)
23-Jan-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1629.20
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 885.00
Lupin 2170.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×